Home > Compound List > Product Information
4-Piperidineethanol_Molecular_structure_CAS_622-26-4)
Click picture or here to close

4-Piperidineethanol

Catalog No. P46156 Name Sigma Aldrich
CAS Number 622-26-4 Website http://www.sigmaaldrich.com
M. F. C7H15NO Telephone 1-800-521-8956
M. W. 129.2001 Fax
Purity 97% Email
Storage Chembase ID: 92385

SYNONYMS

Title
4-哌啶乙醇
IUPAC name
2-(piperidin-4-yl)ethan-1-ol
IUPAC Traditional name
4-piperidineethanol
Synonyms
4-(2-羟乙基)哌啶
4-(2-Hydroxyethyl)piperidine

DATABASE IDS

PubChem SID 24898559
EC Number 210-727-7
CAS Number 622-26-4
MDL Number MFCD00006008

PROPERTIES

Empirical Formula (Hill Notation) C7H15NO
Purity 97%
Boiling Point 131-136 °C/17 mmHg(lit.)
Flash Point 113 °C
Flash Point 235.4 °F
Melting Point 46-47 °C(lit.)
Refractive Index n20/D 1.4902(lit.)
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment Eyeshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26-37/39
German water hazard class 3

DETAILS

Description (English)
Packaging
1, 5 g in glass bottle
Application
Reactant for synthesis of:
• Ursolic acid derivatives1
• Amodiaquine analogues for treatment of cerebral malaria2
• Spiroimidazolidinone NPC1L1 inhibitors3
• Piperazinyl glutamate pyridines as orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation4
• Neurokinin-2 receptor antagonists5
• Hepatitis C virus NS5B polymerase inhibitors6
Description (简体中文)
包装
1, 5 g in glass bottle
Application
Reactant for synthesis of:
• Ursolic acid derivatives1
• Amodiaquine analogues for treatment of cerebral malaria2
• Spiroimidazolidinone NPC1L1 inhibitors3
• Piperazinyl glutamate pyridines as orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation4
• Neurokinin-2 receptor antagonists5
• Hepatitis C virus NS5B polymerase inhibitors6

REFERENCES